Cell Expansion Market Trends, Growth And
Future Outlook By 2026
Cell expansion is the large scale artificial production of daughter cells from a single cell, to
support medical research. Rising preference for regenerative medicines offering faster results,
and emergence of cell-based therapies with high patient compatibility are expected to fuel the
cell expansion market during the forecast period (2017–2025). Regenerative medicine helps the
body to form new functional tissue to replace defective or lost ones providing treatment for
conditions with inadequate therapies. According to the U.S. Department of Health and Services,
in 2016, NIH invested around US$ 1.5 billion in stem cell research projects. Increasing
government and private sector expenditure on cell-based research therapies is expected to boost
growth of the market for cell expansion in the near future. The number of FDA approvals for
clinical trials of stem cell-based treatments is rapidly increasing. According to a report
published by Pharmaceutical Research and Manufacturers of America, in 2013, around 69 cell
therapies with clinical trials were under review with the FDA. The therapeutic classes
represented in these trials include skin diseases, cardiovascular diseases, transplantations, eye
conditions, cancer and associated conditions, musculoskeletal disorders, genetic disorders, and
digestive disorders.
Request PDF Brochure Of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1293
Increasing incidence of chronic medical conditions is expected to boost growth of the cell
expansion market over the forecast period
The increasing cases of chronic and rare medical conditions around the world is another key
factor driving demand for cell expansion. For instance, according to World Health Organization
(WHO), around 15 million people are projected to suffer from cancer by 2020. The rising
prevalence of cancer, is in turn, expected to boost growth of the cell expansion market. Cell-
based therapy is also a promising approach for treating chronic kidney disease and is presently
the focus of preclinical studies. Recent advancements in regenerative medicine and tissue
engineering have created cell-based approaches for the treatment of renal failure. Such
treatments include biotechnological approach using implantation of bioengineered kidney